AbbVie cuts ties with Google-backed longevity company, lays off scientists

Taking stock of the drug industry, from the lab to the medicine chest

November 12, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Ruby Wallau for STAT STAT+ | AbbVie cuts ties with Google-backed longevity company, lays off scientists The pharma giant is severing a collaboration that began in 2014 with a $1.5 billion agreement to find longevity-boosting medicines. By Damian Garde STAT+ | How two top FDA officials are quietly upending vaccine regulations Vinay Prasad and Tracy Beth Høeg mix skepticism and mistrust of career scientists with new ways to define risk in pursuing sweeping changes to vaccine policy. By Lizzy Lawrence STAT+ | Why Richard Pazdur taking over the FDA's drug division is good for patients — and drug companies The Food and Drug Administration official has been able to approve new treatments more quickly, on less data, without sacrificing rigor By Matthew Herper

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser